Skip to contentApplication 206947
- Type
- NDA
- Sponsor
- EISAI INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LENVIMA | LENVATINIB MESYLATE | CAPSULE;ORAL | EQ 4MG BASE | Yes | No |
| 002 | LENVIMA | LENVATINIB MESYLATE | CAPSULE;ORAL | EQ 10MG BASE | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | NDA | Current |